News

A high rate of response to neoadjuvant PD-1 blockade in patients with desmoplastic melanoma suggests such therapy could reduce the extent of surgery needed on the face and neck.

Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma

Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO

Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy

Major financial hardship common after cancer diagnosis, despite insurance

Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo

Analyses presented at ASH 2021 find statistical models can predict risk of early death with non-intensive AML therapy

Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients